CareDx, Inc
CareDx, Inc (CDNA) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
cdna · pe ratio · data through Dec 31, 2025
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for CareDx, Inc (CDNA) measures how much investors pay for each dollar of the company's trailing earnings. CDNA's current PE ratio of N/A is calculated by dividing its stock price of $22.39 by its TTM earnings per share of -$0.16.
Source: FMP · /ratios-ttm · /analyst-estimates · 2025-12-31
PE Ratio History
2012 – 2025 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
PE Ratio vs Peers
Medical - Diagnostics & Research · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
CareDx, IncYou CDNA | $1.2B | N/A | — | -$0.16 |
 CorMedix Inc. CRMD | $663M | 5.14x | -25.3% | $2.26 |
 Castle Biosciences, Inc. CSTL | $635M | N/A | — | -$0.83 |
 DarioHealth Corp. DRIO | $55M | N/A | — | -$0.84 |
 Embecta Corp. EMBC | $199M | 8.62x | +25.3% | $1.64 |
 Evolent Health, Inc. EVH | $515M | N/A | — | -$4.68 |
 Fulgent Genetics, Inc. FLGT | $544M | N/A | — | -$1.97 |
Industry Average 2 peers with valid PE | — | 6.88x | baseline | — |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2025-12-31Latest FY2025 | — | $-0.40 | — | |
2024-12-31 FY2024 | 21.50x | $1.00 | — | |
2023-12-31 FY2023 | — | $-3.54 | — | |
2022-12-31 FY2022 | — | $-1.44 | — | |
2021-12-31 FY2021 | — | $-0.59 | — | |
2020-12-31 FY2020 | — | $-0.40 | — | |
2019-12-31 FY2019 | — | $-0.52 | — | |
2018-12-31 FY2018 | — | $-1.31 | — | |
2017-12-31 FY2017 | — | $-2.38 | — | |
2016-12-31 FY2016 | — | $-2.39 | — |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for CareDx, Inc (CDNA) measures how much investors pay for each dollar of the company's trailing earnings. CDNA's current PE ratio of N/A is calculated by dividing its stock price of $22.39 by its TTM earnings per share of -$0.16.
Frequently asked questions
CDNA pe ratio · 6 questionsCDNA's current PE ratio is N/A as of 2026-06-08, based on a stock price of $22.39 and TTM EPS of -$0.16. Data sourced from Financial Modeling Prep via CDNA's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · CareDx, Inc SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-08